Health Care: Drugs

Agenus Inc (AGEN: NASDAQ)

$3.07 -0.05 | -1.6%
08/22/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 3.12
52 Week High 5.27
52 Week Low 2.27
Avg. Daily Vol. (Mil) 0.93
Beta (3 year) 2.16
Share Related Items
Mkt Cap (Mil) 195.56
Shares Out (Mil) 62.68
Float (Mil) 50.00
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.40
Current Ratio 3.60
LT Debt/ Equity 0.00
Total Debt / Equity 0.13
Valuation Ratios
Price Earnings n.a.
Price/Sales 39.72
Price/Book 3.39
Price/Cash Flow -9.50
Per Share Data
Earnings -0.51
Sales 0.08
Book Value 0.92
Cash Flow -0.33
Business Summary
Agenus Inc along with its subsidiaries is a biopharmaceutical company, which is developing and commercializing technologies to treat cancers and degenerative disorders.
General Information
3 Forbes Road
Lexington, MA 02421
www.agenusbio.com
Industry : Drugs
Sector: Health Care
Employees: 114
CEO: Dr. Garo H Armen PhD
Short Interest
Current Month (Mil) 6.41
Previous Month (Mil) 6.18
Short Interest Ratio (Days) 4.80
Management Effectiveness
Return on Equity n.a.
Return on Assets -21.20
Return on Investments -36.80
Profitability
Gross Margin 98.20
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with AGEN

Latest AGEN Headlines from TheStreet

More Financial News for AGEN

Press Releases for AGEN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter